Swiss Life Holding is tracked as a listed Swiss life insurance and financial-solutions holding company, headquartered in Switzerland. Swiss Life combines life and pensions operations with advisor networks and third-party asset management, making it a useful case for separating insurance results, fee businesses, and holding-company capital flows.
Source-reviewed company references
Swiss Life Holding: FY2025 Annual Report / annual report
The annual report provides audited financial statements, segment reporting, governance, risk, and capital context for the 2025 financial year.
Why it matters: This card anchors Swiss Life Holding evidence from FY2025 Annual Report / annual report and preserves the stated disclosure scope.
Official PDF path reviewed. Use segment metrics only for the named business unit and currency.
Official PDF path reviewed. Use segment metrics only for the named business unit and currency.
Swiss Life Holding: Swiss Life Holding Share Record / exchange record
The exchange path supports the listed parent identity and Swiss security record.
Why it matters: This card anchors Swiss Life Holding evidence from Swiss Life Holding Share Record / exchange record and preserves the stated disclosure scope.
Public exchange path inventoried. Do not freeze price, valuation, volume, or performance data.
Public exchange path inventoried. Do not freeze price, valuation, volume, or performance data.
Swiss Life Holding: FY2025 Results Release / full-year results
Net profit was CHF 1.26 billion, profit from operations CHF 1.83 billion, premiums CHF 20.9 billion, fee income CHF 2.59 billion, and return on equity 17.2%.
Why it matters: This card anchors Swiss Life Holding evidence from FY2025 Results Release / full-year results and preserves the stated disclosure scope.
HTTP 200 official release reviewed. The release labels some figures unaudited and uses issuer-defined fee and operating measures.
HTTP 200 official release reviewed. The release labels some figures unaudited and uses issuer-defined fee and operating measures.
Swiss Life Holding: FY2025 Solvency and Operating Context / solvency disclosure
The results materials record an estimated SST ratio around 210%, CHF 1.22 billion cash remittance to holding, and CHF 146 billion third-party assets under management.
Why it matters: This card anchors Swiss Life Holding evidence from FY2025 Solvency and Operating Context / solvency disclosure and preserves the stated disclosure scope.
HTTP 200 reporting hub reviewed. The SST estimate, cash remittance, and third-party assets under management answer different questions and are not additive.
HTTP 200 reporting hub reviewed. The SST estimate, cash remittance, and third-party assets under management answer different questions and are not additive.
Full company reference archive
View the complete source-reviewed company reference archive, including reporting periods, source dates, reviewed dates, methodology notes, reader cautions, and official source links.
Business And Entity Overview
Swiss Life publishes an accessible FY2025 results release and annual-report library with segment, fee-business, asset-management, and SST context. The profile is bounded to Swiss Life Holding Ltd and the consolidated or parent scope identified by each source. It does not transfer group figures automatically to every licensed insurer, branch, brand, or other subsidiary.
Source-Reviewed Evidence
- FY2025 Results Release / full-year results (FY2025, year ended 2025-12-31). Net profit was CHF 1.26 billion, profit from operations CHF 1.83 billion, premiums CHF 20.9 billion, fee income CHF 2.59 billion, and return on equity 17.2%. Scope: Swiss Life Group consolidated with named segments. Caution: HTTP 200 official release reviewed. The release labels some figures unaudited and uses issuer-defined fee and operating measures.
- FY2025 Annual Report / annual report (FY2025, published 2026-04-15). The annual report provides audited financial statements, segment reporting, governance, risk, and capital context for the 2025 financial year. Scope: Swiss Life Group consolidated and disclosed business units. Caution: Official PDF path reviewed. Use segment metrics only for the named business unit and currency.
- FY2025 Solvency and Operating Context / solvency disclosure (FY2025 reporting library). The results materials record an estimated SST ratio around 210%, CHF 1.22 billion cash remittance to holding, and CHF 146 billion third-party assets under management. Scope: Swiss Life Group and named reporting documents. Caution: HTTP 200 reporting hub reviewed. The SST estimate, cash remittance, and third-party assets under management answer different questions and are not additive.
- Swiss Life Holding Share Record / exchange record (Current public issuer record reviewed 2026-07-15). The exchange path supports the listed parent identity and Swiss security record. Scope: Swiss Life Holding Ltd listed share SLHN. Caution: Public exchange path inventoried. Do not freeze price, valuation, volume, or performance data.
Entity Boundary
Use Swiss Life Holding Ltd for the listed parent and Swiss Life Group for consolidated disclosures. Swiss Life Ltd, country businesses, distribution companies, and Swiss Life Asset Managers remain separately scoped subsidiaries and segments. Do not transfer group results or the estimated group SST ratio to Swiss Life Ltd or a country operation. Keep CHF and EUR segment measures and issuer-defined fee measures distinct.
Lines And Geographic Context
The reviewed source pack supports connections to Life and Health. Switzerland is the home-jurisdiction reference; other geographies require their own segment or legal-entity support.
Why This Profile Exists
Keeping the 4 reviewed source cards together gives readers a stable route from corporate identity to periodic reporting, capital or regulatory context, and public listing or profile evidence. The profile does not present a score, comparison table, or commercial recommendation.
Reader Note
This profile is source-led reference material. Periodic figures retain the source's metric label, unit, reporting period, and entity scope. Ratings, regulatory measures, listing records, and issuer-defined measures are contextual evidence, not standalone judgments about financial strength, suitability, security value, product choice, pricing, or available insurance capacity.